Occurrence of serum anti-HLA IgG Ab detected by Flow-PRA 30 days after BMT or PBHSCT
| Ab isotype . | Presence of anti-HLA Ab . | P . | |||
|---|---|---|---|---|---|
| Donors . | Recipients pretransplantation . | Recipients at day +30 . | |||
| PBHSCT (%) . | BMT (%) . | ||||
| Anti-HLA class I IgG | All | All | 10/24 (42) | 3/27 (11) | .02 |
| Negative | Negative | 7/20 (35) | 0/20 | .008 | |
| Positive | Negative | 1/1 | 1/2 | — | |
| Negative | Positive | 2/3 (67) | 2/5 (40) | .5 | |
| Anti-HLA class II IgG | All | All | 5/24 (21) | 1/27 (4) | .09 |
| Negative | Negative | 1/19 (5) | 0/22 | .46 | |
| Positive | Negative | 3/3 | 0/1 | .25 | |
| Negative | Positive | 1/2 (50) | 1/4 (25) | — | |
| Ab isotype . | Presence of anti-HLA Ab . | P . | |||
|---|---|---|---|---|---|
| Donors . | Recipients pretransplantation . | Recipients at day +30 . | |||
| PBHSCT (%) . | BMT (%) . | ||||
| Anti-HLA class I IgG | All | All | 10/24 (42) | 3/27 (11) | .02 |
| Negative | Negative | 7/20 (35) | 0/20 | .008 | |
| Positive | Negative | 1/1 | 1/2 | — | |
| Negative | Positive | 2/3 (67) | 2/5 (40) | .5 | |
| Anti-HLA class II IgG | All | All | 5/24 (21) | 1/27 (4) | .09 |
| Negative | Negative | 1/19 (5) | 0/22 | .46 | |
| Positive | Negative | 3/3 | 0/1 | .25 | |
| Negative | Positive | 1/2 (50) | 1/4 (25) | — | |